Neoadjuvant chemotherapy for high-grade advanced gastric cancer
β Scribed by Yutaka Yonemura; Tosiharu Sawa; Kazuo Kinoshita; Nobuo Matsuki; Sachio Fushida; Sigehiro Tanaka; Shigekazu Ohoyama; Tooru Takashima; Hironobu Kimura; Tooru Kamata; Takashi Fujimura; Kazuo Sugiyama; Kouzou Shima; Itsuo Miyazaki
- Publisher
- Springer
- Year
- 1993
- Tongue
- English
- Weight
- 651 KB
- Volume
- 17
- Category
- Article
- ISSN
- 0364-2313
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Thirty-eight patients with locally advanced breast cancer (Stage HI) were treated over a 3-year period. All patients initially received two cycles of CMF (cyclophosphamide, 100 mg/m2 p.0. dl-14; methotrexate 40mg/m2 intravenously (iv), d l and d8., 5 Fluorouracil 500 mg/m2 iv d l and d8). They were
## Abstract Treatment of gastric cancer has evolved with the advent of randomized trials demonstrating chemotherapeutic agents with efficacy in advanced disease. Level I evidence supports delivering chemotherapy in the neoadjuvant setting; the data shows improvement in progressionβfree and overall